In:
Cancer, Wiley, Vol. 126, No. 3 ( 2020-02), p. 611-618
Abstract:
With greater than 50% of patients who have metastatic melanoma reaching a second line of treatment, an assessment of their quality of life during the whole course disease becomes crucial. In the French MelBase cohort, the quality of life for patients who have metastatic melanoma is fairly stable over time.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
1429-1